ADC Therapeutics Analyst Ratings
BenzingaApr 15 07:50 ET
Buy Rating Affirmed for ADC Therapeutics on Strong Preclinical Data and Promising Trial Progress
TipRanksApr 15 06:16 ET
Analysts Conflicted on These Healthcare Names: ADC Therapeutics (ADCT), Adial Pharmaceuticals (ADIL) and Steris (STE)
TipRanksApr 11 11:30 ET
ADC Therapeutics Analyst Ratings
BenzingaApr 5 09:53 ET
Analysts' Top Healthcare Picks: ADC Therapeutics (ADCT), TFF Pharmaceuticals (TFFP)
TipRanksApr 4 13:20 ET
ADC Therapeutics Analyst Ratings
BenzingaMar 28 06:44 ET
Analysts Conflicted on These Healthcare Names: Veradigm (OtherMDRX), ADC Therapeutics (ADCT) and Sangamo Biosciences (SGMO)
TipRanksMar 15 21:50 ET
Jefferies Cuts ADC Therapeutics Stock Target to $13, Maintains Buy
InvestingMar 13 16:20 ET
Analysts Offer Insights on Healthcare Companies: ADC Therapeutics (ADCT) and Cresco Labs (OtherCRLBF)
TipRanksMar 13 13:30 ET
ADC Therapeutics Analyst Ratings
BenzingaMar 6 08:09 ET
ADC Therapeutics Analyst Ratings
BenzingaFeb 26 10:16 ET
RBC Lifts Price Target on ADC Therapeutics to $8 From $6, 'Encouraged' by Competitive Positioning; Outperform, Speculative Risk Kept
MT NewswiresFeb 26 07:43 ET
RBC Capital Remains a Buy on ADC Therapeutics (ADCT)
TipRanksFeb 26 07:36 ET
ADC Therapeutics Analyst Ratings
BenzingaFeb 20 07:21 ET
Buy Rating Affirmed for ADC Therapeutics With Raised Price Target Amid Promising Clinical Trials and Strong Balance Sheet
TipRanksFeb 20 06:27 ET
RBC Capital Keeps Their Buy Rating on ADC Therapeutics (ADCT)
TipRanksJan 5 20:47 ET
Optimistic Outlook: Buy Rating for ADC Therapeutics Amid Anticipated Clinical Milestones and Strong Financials
TipRanksJan 5 06:31 ET
HC Wainwright & Co. Maintains Buy on ADC Therapeutics, Lowers Price Target to $3
BenzingaNov 20, 2023 10:31 ET
ADC Therapeutics Analyst Ratings
BenzingaNov 20, 2023 10:27 ET
Analysts Offer Insights on Healthcare Companies: Akoya Biosciences (AKYA), Paycor HCM (PYCR) and ADC Therapeutics (ADCT)
TipRanksNov 9, 2023 05:51 ET
No Data
No Data